Research Highlights


Popular Herb 'Goldenseal' Lowers Cholesterol in Lab Tests

September 21, 2006

This article was taken from VA Research Currents, September 2006.

Animal and cell-culture tests by a team at the VA Palo Alto Health Care System have shown that goldenseal root, a popular North American herb used mainly to fight upper respiratory infections, may also be an effective cholesterol-lowering agent. The findings appeared online last month in the Journal of Lipid Research and are scheduled to appear in print next month.

According to senior investigator Jingwen Liu, PhD, this would be a heretofore unreported application for goldenseal, one of the five top-selling herbs in the U.S. "The cholesterol-lowering effect of goldenseal has never been reported in the literature," said Liu, a molecular biologist.

Previous research by Liu and colleagues found that berberine, an alkaloid found in goldenseal and other herbs, could lower lipids. In a small clinical trial published in 2004 in Nature Medicine, a group of Liu's collaborators in China treated 32 hyperlipidemic patients with berberine isolated from the traditional Chinese herb huang lian, or coptis chinensis—used, like goldenseal, mainly as an antimicrobial. On average, the patients' cholesterol and triglyceride levels dropped by about a third.

In the new research, conducted solely in Liu's VA lab, goldenseal root proved more powerful than berberine by itself as an agent against high cholesterol. Based on the evidence from her cell-culture and hamster experiments, Liu believes that other compounds in goldenseal, in addition to berberine, work in concert to keep lipids in check. Her team identified one of these compounds as canadine. They are working to purify and characterize two others.

The study showed that the compounds boost the production of a protein known as LDLR (liver low-density lipoprotein receptor). Anchored to the surface of liver cells, LDLR grabs particles of LDL, or "bad," cholesterol from the blood and draws them inside the cell. This lowers cholesterol in the bloodstream.

Statin drugs—used by millions of Americans to lower cholesterol—accomplish the same job, but they do so by blocking an enzyme that enables natural production of cholesterol in the liver. When the liver is low in cholesterol, this activates LDLR and liver cells take in more harmful lipids from the bloodstream. Statins have been studied for other possible cardiovascular and antiinflammatory benefits, but their side effects could include liver and muscle damage.

"Because the bioactive components in goldenseal lower cholesterol by a mechanism different from [that of] statins, goldenseal could be used in combination therapy" with statins to improve their efficacy, said Liu. "In addition, for those patients who do not tolerate statins due to muscle pain, goldenseal could be an alternative." She emphasized that the herb's safety and efficacy for this purpose would need to be evaluated in clinical testing.

Liu's VA collaborators included Parveen Abidi, PhD; Wei Chen, MD; Fredric B. Kraemer, MD; and Hai Li, PhD. Their work was supported by VA and the National Center for Complementary and Alternative Medicine.